Commercialization
for Biotechnology
Companies
Therapeutics. Contract services. Supporting technologies. We help biotechs build the commercial story and execution to reach investors, partners, and buyers at every stage.
The Biotech
Commercialization
Challenge
Biotechs operate under a specific tension: the science has to be rigorous and credible to your scientific and investor audience, and it has to be accessible and compelling to the broader partners, press, and public stakeholders you need on your side. Most agencies can do one or the other. The ones who can do both, and who can do it at the pace a biotech operates, are rare. Our writers hold advanced degrees in the sciences. We produce technically credible content that earns the trust of a scientifically trained audience without requiring you to re-educate us on the biology.
Funding, Partnerships,
and the Commercial Stage
We've worked with biotechs at seed stage, Series A, Series B, and at commercial launch. The commercial needs are different at every stage. At the early stage, the job is almost entirely investor- and partner-facing: a clear scientific narrative, a credible founding team story, VC targeting, and the pitch deck and supporting assets that open doors. We've helped shepherd several biotech clients through acquisition. At the commercial stage, the job shifts to demand generation and sales enablement: reaching lab directors, formulary committees, hospital systems, or direct consumers depending on your model. We build the programs that fill the pipeline and support your commercial team in closing.
Contract Services
and Supporting
Technologies
Biotech isn't only therapeutics. CROs, CDMOs, reagent companies, and supporting technology providers are some of the hardest companies to market, because your buyers are scientists who are skeptical of marketing by training. We understand that buyer intimately and we know how to earn their trust without losing their respect. For CROs and CDMOs specifically: your best marketing assets are technical. Application notes, white papers, scientific posters, case studies. We produce all of it, at the level of rigor your audience expects.
Your science is ready.
Ready to
Commercialize?
Two paths in. Pick the one that fits.